Litigation is expensive, and the cost of pursuing a legitimate claim can be enough to stop it from being brought at all. A litigation funding agreement is the contract that governs one established way around that problem: an outside party pays some or all of a case’s legal costs in exchange for a share of any recovery. The idea is simple. The document that makes it work is not.
This guide explains what these agreements are, how a case moves from first contact to signed contract, and which provisions a typical agreement covers. It also flags where the rules differ by jurisdiction, because in litigation finance they frequently do.
What a litigation funding agreement actually is
A litigation funding agreement – often shortened to LFA – is a contract between a party to a dispute, usually the claimant, and a third party that has no other connection to the case. The third party, known as the funder, agrees to pay some or all of the legal fees and expenses needed to pursue the claim. In exchange, it receives an agreed share of the proceeds if the case ends successfully, whether through settlement or judgment.
The arrangement is generally non-recourse. That single word carries much of the risk allocation: if the claim fails, the funder typically receives nothing and has no right to recover the money it advanced. The Federal Judicial Center’s overview of third-party litigation finance describes the practice as obtaining financial assistance from a funder in exchange for an interest in the potential recovery, and notes that the agreement is usually non-recourse.
Funding began in the personal injury context in the United States. From roughly 2010 it spread into intellectual property, antitrust, business contract disputes and commercial arbitration, and it is now a familiar feature of international arbitration as well. In many cross-border disputes the funder sits alongside other financial instruments, such as insurance against adverse costs, that together shape how a claim is financed.
Consumer funding and commercial funding are not the same product
It helps to separate two markets that share a name. Consumer funding usually involves an individual pursuing a claim such as a personal injury or family matter. Commercial funding usually involves a business, a class action, or mass tort litigation. The Federal Judicial Center draws this distinction, and it matters because the economics, the typical counterparties and the applicable rules can differ considerably between the two.
| Feature | Consumer funding | Commercial funding |
|---|---|---|
| Typical claimant | An individual | A business, class representative, or group of claimants |
| Typical dispute | Personal injury, family, small-value claims | Intellectual property, antitrust, contracts, arbitration |
| Common structure | Single claim, often a cash advance | Single case or a portfolio of cases |
| Usual financial form | Financing tied to recovery | Non-recourse investment |
Source: Federal Judicial Center, “Third-Party Litigation Finance” (2017). Categories are general descriptions; individual arrangements vary.
Consumer and commercial agreements are worded differently, but both tend to follow a similar sequence before money changes hands.
How a case moves from first contact to signed agreement
Most funders work in stages. The process usually begins with a short assessment and, if it looks promising, a term sheet that records the indicative commercial terms. The term sheet often grants the funder a short period of exclusivity to review the case in more detail – industry commentary frequently cites a window of around 30 days, though this is negotiated and not fixed.
- Initial review. The funder forms a first view of the merits, the likely recovery, and the anticipated budget.
- Term sheet and exclusivity. The headline economics are agreed before significant time is spent on the full contract.
- Due diligence. Legal, financial, and technical questions are examined, and the case may be declined at any point.
- Drafting and negotiation. The LFA converts the term sheet into binding obligations, alongside related documents such as the lawyers’ retainer and any insurance policy.
- Execution and drawdowns. Funds are typically released in stages as fees and expenses are incurred, rather than as a single lump sum.
Where the recovery is used to pay ongoing legal costs, the funder will often pay the law firm or other service providers directly. Where the claimant is instead monetizing part of a future recovery, a single upfront payment is more common. Both patterns appear in the market, and the choice affects how the rest of the contract is written.
What the agreement covers
The LFA is the document that ties the commercial bargain to the practical realities of running a case. While no two agreements are identical, the ICLG overview of litigation funding and other practitioner guides identify a recurring set of provisions.
The budget and funding mechanics
The agreement normally attaches or incorporates a budget that maps spending across the phases of the case. Funders typically treat an unrealistic budget as a warning sign, and the budget often defines the maximum amount the funder is committed to provide. It may also set caps on lawyers’ fees or provide for unallocated contingencies.
The payment waterfall
At the centre of most funding contracts is the waterfall: the order in which any recovery is divided among the funder, the lawyers, any insurer, and the claimant. A common structure repays the funder’s advanced amount first, sometimes plus a minimum return, with the balance shared according to an agreed formula. Because small differences in defined terms can change the outcome materially, the waterfall tends to be among the most heavily negotiated sections.
Control over the litigation
Funders generally present themselves as passive investors with no day-to-day control over strategy or settlement. In practice, many agreements require the funder’s consent before a settlement is accepted, and some impose limits on replacing counsel or changing the theory of the case. Where the line sits between legitimate protection of an investment and impermissible control is a question of degree, and it is treated differently across jurisdictions.
Termination rights
Because the funder usually stays out of the conduct of the case, termination provisions may be its main lever if something goes wrong. These are often triggered by a material adverse development, such as the resignation of counsel, and the agreement will state what happens to sums already advanced.
Representations, warranties, and information rights
Claimants typically make representations about their ownership of the claim and the absence of competing liens. The agreement may also set out what the claimant must disclose to the funder, and how confidential or privileged material is to be handled.
Non-recourse means the funder carries the downside
It is worth restating what non-recourse actually means, because it is the feature that distinguishes funding from an ordinary loan. The funder’s return is paid from the proceeds of the case, and if there are no proceeds, there is typically nothing to pay. That is why funders spend heavily on assessing the merits, the damages, and – increasingly – the likely duration of a case. Duration risk, or how long it takes a court or tribunal to resolve a dispute, sits largely outside the parties’ control, and it is one reason portfolio arrangements and secondary sales of funding positions have developed.
Pricing usually reflects that risk. A funder may express its return as a percentage of the recovery or as a multiple of the amount advanced. Some jurisdictions cap or restrict percentage-based models. In England and Wales, for example, the Supreme Court’s 2023 decision in the PACCAR case held that certain percentage-based funding returns fell within the statutory definition of a damages-based agreement and were therefore unenforceable as structured, which prompted many agreements to move toward a multiple-of-investment approach.
Disclosure and regulation: a patchwork, not a single rule
There is no single global rule governing litigation funding agreements. In the United States, several states have enacted statutes touching on funding, and some federal districts have adopted disclosure requirements through local rules or standing orders. Reuters reported in September 2026 that the U.S. District Court for the Western District of Louisiana added a standing order requiring parties to identify funders and to indicate whether a funder has any right to approve or influence litigation decisions, including settlement.
Federal legislation has been proposed but not enacted, and the rules continue to evolve. Some frameworks focus on transparency, requiring disclosure of who is funding a case. Others regulate the conduct of funders directly, restricting their involvement in decisions or limiting the charges they may impose in consumer matters. Because these rules are jurisdiction-specific, the answer to “must this be disclosed?” is best confirmed by reference to the court and the governing law for a particular matter.
As the market has matured, funding has moved from isolated single-case arrangements toward structured portfolios and, in some jurisdictions, a secondary market in which funders may transfer positions. For broader industry context, these developments have drawn coverage from both legal trade publications and the general business media.
Questions readers ask most often
Is litigation funding legal?
In many jurisdictions it is lawful, but the rules differ. Some places regulate funding through consumer protection statutes, others through court disclosure requirements, and some restrict certain structures or funding sources. The legality of any particular arrangement depends on the governing law and the terms of the agreement.
What happens if the case loses?
Under a typical non-recourse agreement, the funder receives nothing and the claimant generally does not have to repay the advanced amount from their own pocket. Terms vary, however, and a contract may contain limited exceptions, so the specific wording of the agreement controls.
Does the funder control the case?
Usually not in day-to-day terms. Most funders describe themselves as passive investors, and many agreements still require their consent before a settlement is signed. How much influence is permitted is a question of degree and depends on the jurisdiction.
How much does a funder typically take?
There is no universal figure. Funders may price by a percentage of the recovery or a multiple of the amount advanced, and the appropriate level is generally framed as compensation for the risk taken. Some jurisdictions cap consumer funding charges by statute.
Do funding agreements have to be disclosed?
It depends on where the case is heard. A number of U.S. states and some federal courts require disclosure, while other jurisdictions do not impose a general obligation. Where disclosure is required, the scope – names only, or the agreement itself – varies.
How is funding different from a loan?
The key difference is recourse. A loan creates an obligation to repay regardless of outcome, while funding is generally repayable only from the proceeds of the case. That distinction can affect which laws apply, including licensing and usury rules.
A contract that decides who carries the risk
Strip away the terminology and a litigation funding agreement answers a sequence of practical questions: who pays as the case proceeds, what happens if it fails, in what order a recovery is shared, and who gets to make the decisions along the way. The answers are negotiated case by case, and they shift with the law of the jurisdiction hearing the dispute.
For a claimant weighing funding, the useful exercise is not to memorize a standard template but to read the specific agreement against those questions and to confirm the current rules where the case will be heard. For everyone else, the value of understanding these contracts is simpler: they reveal that the cost and risk of litigation are not fixed facts but choices that parties distribute by agreement.
